Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before they become widespread. This approach could significantly support public ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to ...

The world map shows the countries and regions for which master data analyses for SARS-CoV-2 are available. The darker the red, the more data is available. The data comes from GISAID and the WHO. Since ...

Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

In a new study, researchers at Yale University performed surveillance to understand the current coronaviral landscape of wild and domestic animals in the northeastern United States. They found that ...

As of May 2023, the WHO recommends the use of a monovalent XBB.1 descendent lineage, such as omicron XBB.1.5, as the vaccine antigen for COVID-19 vaccines. However, BA.2.86 and its descendent lineages ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

In a large, population-based cohort, previously healthy children and adolescents who experienced acute SARS-CoV-2 infection had more than twice the risk of developing type 1 diabetes (T1D) within 6 ...